Vismodegib for Preservation of Visual Function in Patients with Advanced Periocular Basal Cell Carcinoma: The VISORB Trial

BACKGROUND: Basal cell carcinoma (BCC) is a common skin cancer often curable by excision; however, for patients with BCC around the eye, excision places visual organs and function at risk. In this article, we test the hypothesis that use of the hedgehog inhibitor vismodegib will improve vision‐relat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncologist
Autors principals: Kahana, Alon, Unsworth, Shelby P., Andrews, Christopher A., Chan, May P., Bresler, Scott C., Bichakjian, Christopher K., Durham, Alison B., Demirci, Hakan, Elner, Victor M., Nelson, Christine C., Kim, Denise S., Joseph, Shannon S., Swiecicki, Paul L., Worden, Francis P.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Inc. 2021
Matèries:
Melanoma and Cutaneous Malignancies
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8265335/
https://ncbi.nlm.nih.gov/pubmed/33988881
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/onco.13820
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars